This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement

Stocks in this article: LDR

GLENWOOD, Ill., July 24, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Peter Cempellin to President of Landauer's Radiation Measurement segment effective immediately.

"Pete's previous professional experiences will make him a great addition to Landauer. His involvement with a very dynamic business in positron emission tomography (PET/CT) coupled with his leadership in delivering the first ever commercially viable, FDA approved Time-OF-Flight PET/CT System, is quite impressive.  This was a market changing disruptive technology that changed the imaging landscape," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.

In this role, Mr. Cempellin will direct and lead the strategic and operating direction for the Dosimetry Products and Services Business. He will have responsibility for the firm's manufacturing operations, technical laboratory services and international channel partners within the corporation's radiation measurement business segment.

Prior to Landauer, Mr. Cempellin served as President and CEO of CAE Healthcare Inc., a provider of simulation training products including surgical, patient, and ultrasound imaging simulators addressing the educational needs of surgeons, gastroenterologists, cardiologists and intensivists.

Before joining CAE Healthcare, Mr. Cempellin held a variety of executive management positions including Vice President and General Manager at Analogic Corporation, a manufacturer of diagnostic computed tomography (CT) systems and image guided radiation therapy systems (IG-IMRT) and also served as General Manager of Philips Healthcare's Nuclear Medicine Business including PET/CT and molecular imaging systems. Under Mr. Cempellin, Philips Healthcare created the world's first Time-of-Flight PET/CT system, a breakthrough in medical imaging diagnostics and also initiated the world's first whole body PET/MR imaging system.

"Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Cempellin.  "Given the company's strong position in occupational and patient radiation monitoring and services, I believe there are extraordinary opportunities to grow and build shareholder value. I look forward to working closely with Landauer employees, as well as customers, shareholders and business partners."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs